JP2023515565A5 - - Google Patents

Info

Publication number
JP2023515565A5
JP2023515565A5 JP2022551040A JP2022551040A JP2023515565A5 JP 2023515565 A5 JP2023515565 A5 JP 2023515565A5 JP 2022551040 A JP2022551040 A JP 2022551040A JP 2022551040 A JP2022551040 A JP 2022551040A JP 2023515565 A5 JP2023515565 A5 JP 2023515565A5
Authority
JP
Japan
Prior art keywords
aryl
heteroaryl
cancer
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022551040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/054559 external-priority patent/WO2021170658A1/en
Publication of JP2023515565A publication Critical patent/JP2023515565A/ja
Publication of JP2023515565A5 publication Critical patent/JP2023515565A5/ja
Pending legal-status Critical Current

Links

JP2022551040A 2020-02-25 2021-02-24 Ｎｒ２ｆ６を調節する複素環式化合物 Pending JP2023515565A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062981418P 2020-02-25 2020-02-25
US62/981,418 2020-02-25
US202163139262P 2021-01-19 2021-01-19
US63/139,262 2021-01-19
PCT/EP2021/054559 WO2021170658A1 (en) 2020-02-25 2021-02-24 Heterocyclic compounds for modulating nr2f6

Publications (2)

Publication Number Publication Date
JP2023515565A JP2023515565A (ja) 2023-04-13
JP2023515565A5 true JP2023515565A5 (https=) 2024-02-29

Family

ID=74797908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022551040A Pending JP2023515565A (ja) 2020-02-25 2021-02-24 Ｎｒ２ｆ６を調節する複素環式化合物

Country Status (12)

Country Link
US (1) US20220213061A9 (https=)
EP (1) EP4110758A1 (https=)
JP (1) JP2023515565A (https=)
KR (1) KR20220158228A (https=)
CN (2) CN118878514A (https=)
AU (1) AU2021226974A1 (https=)
BR (1) BR112022016941A2 (https=)
CA (1) CA3167785A1 (https=)
IL (1) IL295456B1 (https=)
MX (1) MX2022010456A (https=)
TW (1) TW202140447A (https=)
WO (1) WO2021170658A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023042914A1 (en) * 2021-09-17 2023-03-23 Otsuka Pharmaceutical Co., Ltd. Pyrrolidine compounds as histone deacetylase inhibitors
WO2025106383A1 (en) * 2023-11-17 2025-05-22 Merck Sharp & Dohme Llc Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators
KR20250173438A (ko) * 2024-05-30 2025-12-10 삼진제약주식회사 Nr2f6 억제제 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040094806A (ko) * 2002-03-18 2004-11-10 교린 세이야꾸 가부시키 가이샤 내성균에 유효한10-(3-시클로프로필아미노메틸-1-피로리디닐)피리도벤즈옥사진 카르본산 유도체
WO2005016000A1 (en) * 2003-08-05 2005-02-24 Avalon Pharmaceuticals Derivatives of cyclic quinone and uses thereof
US7138423B2 (en) * 2004-07-20 2006-11-21 Bristol-Myers Squibb Company Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
EP1957450B1 (en) * 2005-12-01 2009-06-24 F.Hoffmann-La Roche Ag Serotonin transporter (sert) inhibitors
JP2011507850A (ja) * 2007-12-21 2011-03-10 ザ スクリプス リサーチ インスティチュート Ｒｈｏキナーゼインヒビターとしてのアニリドおよびアナログ
US8450344B2 (en) * 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
WO2010024903A1 (en) * 2008-08-29 2010-03-04 Yangbo Feng BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS
WO2010059922A1 (en) * 2008-11-21 2010-05-27 Ligand Pharmaceuticals Incorporated Pyrrolidine carboxamide compounds
WO2015070170A1 (en) * 2013-11-08 2015-05-14 The Translational Genomics Research Institute Compounds for cognitive enhancement and methods of use thereof
US10472351B2 (en) * 2016-07-18 2019-11-12 Zander Therapeutics, Inc. Small molecule agonists and antagonists of NR2F6 activity in animals
US11324719B2 (en) * 2016-07-18 2022-05-10 Kcl Therapeutics, Inc. Small molecule agonists and antagonists of NR2F6 activity in humans
CN107674013B (zh) * 2016-08-02 2022-05-24 上海迪诺医药科技有限公司 多环化合物、其制备方法、药物组合物及应用
AU2018221148B2 (en) * 2017-02-17 2022-05-05 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN110776521A (zh) * 2019-10-24 2020-02-11 秦源生物医药科技(上海)有限公司 一种1,2,4-三唑-1,3,4-噻二唑类化合物及其应用

Similar Documents

Publication Publication Date Title
JP2023515565A5 (https=)
JP7158382B2 (ja) Ｃ－ｋｉｔ阻害剤としてのアミノチアゾール化合物
JP2023105175A (ja) グルクロニド薬物－リンカーの調製のためのプロセスおよびその中間体
CN113766954A (zh) 喜树碱衍生物
CN111386265A (zh) 作为pd1/pd-l1活化的抑制剂的嘧啶衍生物
CN112300180B (zh) 一种irak4激酶抑制剂及其制备方法
JP2019514883A5 (https=)
KR20080068084A (ko) 씨씨-1065 유사체를 제조하기 위한 방법 및 화합물
JP2020506951A5 (https=)
JP2021535207A5 (https=)
CN118772176A (zh) 一种嘧啶并芳环化合物及其制备方法和用途
WO2017165851A1 (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
JP2021529814A (ja) 化学化合物
WO2024020536A1 (en) Hexacyclic topoisomerase inhibitors having cytotoxic activity on cancer cells
WO2023217227A1 (zh) 喜树碱类衍生物及配体-药物偶联物
JP2025503322A5 (https=)
WO2019137201A1 (zh) 杂芳基并四氢吡啶类化合物、其制备方法、药物组合物及应用
IL273387B2 (en) Thylanstatin analogs
JP2022500476A (ja) 環状ジヌクレオチド類似体、その医薬組成物及び使用
JP2024523422A5 (https=)
CN105164138B (zh) 新吗啉基蒽环类抗生素衍生物
JP2023542065A5 (https=)
AU2020338985A1 (en) Substituted urea dihydroorotate dehydrogenase inhibitors
JP2025501765A5 (https=)
CN111662295A (zh) 一种irak4激酶抑制剂及其制备方法